基于真实世界数据的发泡胶定位垫不良事件风险研究OA
Study on risk of adverse events of fixation cushion with Styrofoam on the basis of RWD
目的:分析发泡胶定位垫不良事件种类及风险原因,提出风险应对措施,降低产品使用风险.方法:回顾性选取2018年1月至2025年6月福建医科大学附属第一医院使用发泡胶定位垫的174例不良事件报告数据,其中158例不良事件为486例患者(头颈部45例、胸部148例、腹部227例、四肢66例)使用发泡胶定位垫后发生的不良事件,16例不良事件为2名临床操作技师制作发泡胶定位垫过程中发生的不良事件,通过这些不良事件研究分析发泡胶定位垫制作使用中的风险因素.结果:486例放射治疗患者中32.51%(158/486)患者使用发泡胶定位垫后发生皮肤发红、皮肤红肿等不良事件.不同固定部位中头颈部定位患者的不良事件发生率最高为57.78%(26/45),胸部、腹部和四肢不良事件发生率分别为29.06%(43/148)、30.37%(69/227)和30.30%(20/66),不同固定部位间不良事件发生率比较差异有统计学意义(x2=15.84,P<0.01);而年龄和性别对不良事件发生率的影响差异无统计学意义(P>0.05).174例不良事件中严重报告占比1.15%(2/174)、一般报告占比98.85%(172/174).174例不良事件涉及的主要伤害为皮肤发红(占90.23%)、刺激鼻黏膜(占3.45%)、污染皮肤(占1.15%)和皮肤红肿(占0.57%);器械故障主要为发泡不充分(占4.02%)和爆瓶(占0.57%),皮肤发红和爆瓶的风险程度较高.发泡胶定位垫发生风险原因主要包括产品使用说明书不完善、产品不含防水袋、发泡胶液有刺激性、发泡不充分、临床操作不熟练和患者因素等.结论:根据风险评估结果,提出应对措施及风险控制方案:发泡胶定位垫临床使用及操作人员应充分认识该产品的使用风险,严格按照制作流程操作,降低临床操作风险;产品备案人应加强该产品上市后的研究和风险管理,改进产品设计,促进产品迭代升级,降低产品使用风险.
Objective:To analyze the types and risk reasons of adverse events of fixation cushion with Styrofoam,and propose corresponding countermeasures for risks,so as to reduce risks of using it.Methods:The data of 174 adverse events of fixation cushion with Styrofoam that were used at The First Affiliated Hospital of Fujian Medical University during January 2018 and June 2025 were retrospectively selected.The 158 adverse events of them occurred in 486 patients(45 cases were at head and neck,and 148 cases were at chest,and 227 cases were at abdomen,and 66 cases were at limbs)who occurred adverse events after the fixation cushion with Styrofoam was used.In addition,16 adverse events occurred in the process that 2 technicians,who conducted clinical operation,made the fixation cushion with Styrofoam.The risk factors of making and using these fixation cushions with Styrofoam were researched and analyzed through these adverse events.Results:Among 486 patients who received radiotherapy,32.51%(158/486)of patients occurred adverse events included skin redness and skin swelling after used fixation cushion with Styrofoam.For different fixation parts,the incidence of adverse events of patients,whose fixation part was head and neck,was the highest[57.78%(26/45)],and the incidences of that at chest,abdomen and limbs were respectively 29.06%(43/148),30.37%(69/227)and 30.30%(20/66).The difference of the incidences of adverse events among different fixation parts was significant(x2=15.84,P<0.01).The differences of the effects of age and gender on incidence of adverse events among different fixation parts were not significant(P>0.05).In 174 adverse events,the ratio of severe reports was 1.15%(2/174),and the ratio of general reports was 98.85%(172/174).The involved main injuries of 174 adverse events included skin redness(90.23%),nasal mucosa irritation(3.45%),contaminated skin(1.15%),and redness and swelling of skin(0.57%).The failure of apparatus mainly included insufficient foaming(4.02%)and explosion of bottle(0.57%).The risk levels of skin redness and explosion of bottle were higher.The reason of occurring risk of fixation cushion with Styrofoam mainly included imperfect user manual of products,products without waterproof bags,Styrofoam liquid with irritant,insufficient foaming,unskilled clinical operation,reasons from patients,and so on.Conclusion:Clinical users and operators of fixation cushion with Styrofoam should fully understand the risks of using it,and strictly implement operation as production process,so as to reduce risks of clinical operation.The registrants of this product should strengthen management for research and risk after the product enters market,and improve the design of product,and promote iteration and upgrading of product,and reduce risk of using it.
施丽霞;陈龙建;周瑾;洪金省;郭飞宝;林嵘;陈深
福州市市场监管监测服务中心 福州 350014福建医科大学附属第一医院放疗科 福州 350005福州市市场监管监测服务中心 福州 350014福建医科大学附属第一医院放疗科 福州 350005福建医科大学附属第一医院放疗科 福州 350005福州市市场监管监测服务中心 福州 350014福州市市场监管监测服务中心 福州 350014
医药卫生
发泡胶发泡胶定位垫不良事件风险分析
StyrofoamFixation cushion with StyrofoamAdverse eventRisk analysis
《中国医学装备》 2026 (5)
113-118,6
福建省药品监督管理局科技计划项目(2023-11) Science and Technology Program Project of Fujian Medical Products Administration(2023-11)
评论